Glucagon-like peptide-2 and its therapeutic use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2011
Issued Date -
N/A
app pub date -
Jan 5, 2006
filing date -
Apr 14, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Glucagon-like peptide 2, a product of glucagon gene expression, and analogs of glucagon-like peptide 2, have been identified as gastrointestinal tissue growth factors. Their effects on the growth of small bowel and pancreatic islets are described. Their formulation as a pharmaceutical, and their therapeutic use in treating disorders of the bowel, are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully